Serum Anticholinergic Activity in a Community-Based Sample of Older Adults

Authors:
  • BPBruce G. Pollock
    Bruce G. Pollock
  • MKMargaret Kirshner
    Margaret Kirshner
  • CSChangyu Shen
    Changyu Shen
  • HDHiroko Dodge
    Hiroko Dodge
  • MGMary Ganguli
    Mary Ganguli
Open Access
Publisher website
Google Scholar
Abstract
FOR MORE THAN 100 years, clinicians have recognized that drugs with anticholinergic properties are associated with an acute and reversible confusional state, eg, what we now call delirium, particularly in older patients.1-3 The centrally acting cholinomimetic agent physostigmine salicylate has been used to treat anticholinergic delirium since the mid 1800s,1 and conversely, scopolamine hydrobromide, a powerful anticholinergic drug, has been used to induce and study these confusional states experimentally.4-7 Drugs that have high central anticholinergic effects, ie, those that have a high propensity to antagonize muscarinic receptors, are particularly likely to be implicated in these confusional states.8-11

This publication has 36 references indexed in Scilit: